

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 8.96647413 |
| 2 | N-acetylneuraminate metabolic process (GO:0006054) | 8.60585593 |
| 3 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.65622036 |
| 4 | cellular extravasation (GO:0045123) | 7.31802353 |
| 5 | amino sugar catabolic process (GO:0046348) | 7.01980739 |
| 6 | positive regulation of protein deacetylation (GO:0090312) | 6.91194072 |
| 7 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 6.30704081 |
| 8 | purine deoxyribonucleotide catabolic process (GO:0009155) | 6.17976861 |
| 9 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 6.09449517 |
| 10 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.06054431 |
| 11 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.60115313 |
| 12 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.57881948 |
| 13 | regulation of chemokine biosynthetic process (GO:0045073) | 5.54645531 |
| 14 | centriole replication (GO:0007099) | 5.26918305 |
| 15 | regulation of MHC class II biosynthetic process (GO:0045346) | 5.21578292 |
| 16 | negative regulation of phagocytosis (GO:0050765) | 5.14792973 |
| 17 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.06994984 |
| 18 | microglial cell activation (GO:0001774) | 5.01913036 |
| 19 | negative regulation of interleukin-2 production (GO:0032703) | 4.98795057 |
| 20 | regulation of histone deacetylation (GO:0031063) | 4.86055428 |
| 21 | base-excision repair, AP site formation (GO:0006285) | 4.85714099 |
| 22 | angiotensin maturation (GO:0002003) | 4.84710418 |
| 23 | reactive oxygen species biosynthetic process (GO:1903409) | 4.62858959 |
| 24 | macrophage chemotaxis (GO:0048246) | 4.53078444 |
| 25 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.24953327 |
| 26 | regulation of growth of symbiont in host (GO:0044126) | 4.24953327 |
| 27 | negative regulation of growth of symbiont in host (GO:0044130) | 4.24953327 |
| 28 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.24953327 |
| 29 | cytokinetic process (GO:0032506) | 4.16074606 |
| 30 | centriole assembly (GO:0098534) | 4.16043831 |
| 31 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.14359364 |
| 32 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.14359364 |
| 33 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.09841463 |
| 34 | N-acetylglucosamine metabolic process (GO:0006044) | 3.88960157 |
| 35 | glial cell migration (GO:0008347) | 3.80770787 |
| 36 | regulation of fatty acid transport (GO:2000191) | 3.75076119 |
| 37 | response to folic acid (GO:0051593) | 3.67446104 |
| 38 | cellular response to cadmium ion (GO:0071276) | 3.65390199 |
| 39 | regulation of protein import into nucleus, translocation (GO:0033158) | 3.61780266 |
| 40 | response to misfolded protein (GO:0051788) | 3.57643450 |
| 41 | signal complex assembly (GO:0007172) | 3.56461866 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.56083480 |
| 43 | UV protection (GO:0009650) | 3.54892664 |
| 44 | regulation of protein deacetylation (GO:0090311) | 3.34739920 |
| 45 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.33242297 |
| 46 | induction of positive chemotaxis (GO:0050930) | 3.25446241 |
| 47 | heme biosynthetic process (GO:0006783) | 3.23697666 |
| 48 | macrophage activation (GO:0042116) | 3.11817817 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08930344 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08331154 |
| 51 | deoxyribonucleotide catabolic process (GO:0009264) | 3.07895598 |
| 52 | thalamus development (GO:0021794) | 3.06933318 |
| 53 | histone H3 deacetylation (GO:0070932) | 3.02794756 |
| 54 | mannose metabolic process (GO:0006013) | 3.01162441 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.99921237 |
| 56 | respiratory burst (GO:0045730) | 2.98640309 |
| 57 | histone H4 deacetylation (GO:0070933) | 2.96218810 |
| 58 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.95171930 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94190637 |
| 60 | modulation by virus of host process (GO:0019054) | 2.91181883 |
| 61 | negative regulation of cell size (GO:0045792) | 2.90947608 |
| 62 | deoxyribose phosphate catabolic process (GO:0046386) | 2.80434581 |
| 63 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.79000011 |
| 64 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.78990250 |
| 65 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.78988874 |
| 66 | apoptotic process involved in morphogenesis (GO:0060561) | 2.77933291 |
| 67 | regulation of phagocytosis (GO:0050764) | 2.76055922 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73678167 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73678167 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.73678167 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73678167 |
| 72 | modulation by symbiont of host defense response (GO:0052031) | 2.73678167 |
| 73 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73678167 |
| 74 | modulation by symbiont of host cellular process (GO:0044068) | 2.68822013 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 2.68657437 |
| 76 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68282853 |
| 77 | defense response to fungus (GO:0050832) | 2.65790241 |
| 78 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.64968313 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.58574642 |
| 80 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.58098792 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 2.57896649 |
| 82 | positive regulation of phagocytosis (GO:0050766) | 2.52231853 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.51154036 |
| 84 | negative regulation of cell killing (GO:0031342) | 2.51154036 |
| 85 | positive regulation of T cell apoptotic process (GO:0070234) | 2.50794477 |
| 86 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.47948697 |
| 87 | ribosomal small subunit biogenesis (GO:0042274) | 2.44018274 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 2.43670822 |
| 89 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.40284477 |
| 90 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.39530557 |
| 91 | mature B cell differentiation involved in immune response (GO:0002313) | 2.39270771 |
| 92 | lysosome organization (GO:0007040) | 2.38576949 |
| 93 | lytic vacuole organization (GO:0080171) | 2.38576949 |
| 94 | defense response to Gram-negative bacterium (GO:0050829) | 2.36400072 |
| 95 | positive thymic T cell selection (GO:0045059) | 2.36285094 |
| 96 | heme metabolic process (GO:0042168) | 2.32101692 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.30931219 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 2.30673279 |
| 99 | macrophage activation involved in immune response (GO:0002281) | 2.30508214 |
| 100 | response to food (GO:0032094) | 2.29326080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.26853711 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.08278287 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.91145211 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82310450 |
| 5 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.71525628 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.69755734 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52169855 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41701711 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.35319982 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33039251 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30645974 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24389223 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18883571 |
| 14 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.17598201 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.17154313 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11930717 |
| 17 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.09436844 |
| 18 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.07833761 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03791939 |
| 20 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95082451 |
| 21 | P68_20966046_ChIP-Seq_HELA_Human | 1.94494233 |
| 22 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.91566815 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.85263060 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83632584 |
| 25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.82053976 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80169141 |
| 27 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.75200007 |
| 28 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.73524475 |
| 29 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.69884749 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.68863689 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.66439868 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66079905 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65507894 |
| 34 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63011933 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61965165 |
| 36 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.60038946 |
| 37 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.47484932 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46762371 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45704145 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43964594 |
| 41 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.42730431 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39890242 |
| 43 | SA1_27219007_Chip-Seq_Bcells_Human | 1.39551047 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39392144 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38929949 |
| 46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.38835876 |
| 47 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38476122 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38436106 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36763500 |
| 50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33661465 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33126558 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33089305 |
| 53 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30082905 |
| 54 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30043025 |
| 55 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.28727758 |
| 56 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28313083 |
| 57 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28184126 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27640954 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27043997 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26888021 |
| 61 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26616144 |
| 62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.26230171 |
| 63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26211547 |
| 64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26039334 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25313352 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25240990 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24793912 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.24212623 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24091824 |
| 70 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.23537439 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22928397 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22569477 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22537243 |
| 74 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.20307853 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18969179 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18472721 |
| 77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17974092 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17596808 |
| 79 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.16886416 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16682293 |
| 81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16355556 |
| 82 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16182570 |
| 83 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15660347 |
| 84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14979485 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14750067 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14265950 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13623749 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12535735 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11680782 |
| 90 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10010597 |
| 91 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09259051 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08612497 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08151757 |
| 94 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07984146 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07727194 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07307690 |
| 97 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06974962 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06811840 |
| 99 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.06309531 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06043238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 7.28323398 |
| 2 | MP0005670_abnormal_white_adipose | 4.72666686 |
| 3 | MP0008961_abnormal_basal_metabolism | 3.36318039 |
| 4 | MP0005365_abnormal_bile_salt | 3.33001238 |
| 5 | MP0005451_abnormal_body_composition | 3.14781363 |
| 6 | MP0000003_abnormal_adipose_tissue | 2.85870215 |
| 7 | MP0003436_decreased_susceptibility_to | 2.60349262 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.45753378 |
| 9 | MP0003252_abnormal_bile_duct | 2.42520878 |
| 10 | MP0005375_adipose_tissue_phenotype | 2.24345630 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.09643900 |
| 12 | MP0002419_abnormal_innate_immunity | 2.05188322 |
| 13 | MP0009840_abnormal_foam_cell | 1.94882970 |
| 14 | MP0002254_reproductive_system_inflammat | 1.87535036 |
| 15 | MP0005025_abnormal_response_to | 1.80181009 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.77466199 |
| 17 | MP0003172_abnormal_lysosome_physiology | 1.68445624 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.67937310 |
| 19 | MP0005666_abnormal_adipose_tissue | 1.66624522 |
| 20 | MP0004043_abnormal_pH_regulation | 1.66579640 |
| 21 | MP0009115_abnormal_fat_cell | 1.65374396 |
| 22 | MP0006082_CNS_inflammation | 1.61727181 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.60137662 |
| 24 | MP0009278_abnormal_bone_marrow | 1.56984295 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.55295972 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.54615773 |
| 27 | MP0003303_peritoneal_inflammation | 1.52638512 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.50324956 |
| 29 | MP0001819_abnormal_immune_cell | 1.49687662 |
| 30 | MP0001800_abnormal_humoral_immune | 1.43868553 |
| 31 | MP0005387_immune_system_phenotype | 1.41980494 |
| 32 | MP0001790_abnormal_immune_system | 1.41980494 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.40629772 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.37249465 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.36228356 |
| 36 | MP0004947_skin_inflammation | 1.35171105 |
| 37 | MP0002970_abnormal_white_adipose | 1.33907068 |
| 38 | MP0001873_stomach_inflammation | 1.31673795 |
| 39 | MP0009785_altered_susceptibility_to | 1.31219329 |
| 40 | MP0000685_abnormal_immune_system | 1.29851619 |
| 41 | MP0002723_abnormal_immune_serum | 1.26954296 |
| 42 | MP0002933_joint_inflammation | 1.26754498 |
| 43 | MP0008058_abnormal_DNA_repair | 1.25835832 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.25660339 |
| 45 | MP0005671_abnormal_response_to | 1.24864143 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.24009226 |
| 47 | MP0005360_urolithiasis | 1.18026774 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.17811167 |
| 49 | MP0002405_respiratory_system_inflammati | 1.14961010 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.12492163 |
| 51 | MP0000343_altered_response_to | 1.10465523 |
| 52 | MP0005310_abnormal_salivary_gland | 1.09661438 |
| 53 | MP0000858_altered_metastatic_potential | 1.09642656 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.09640582 |
| 55 | MP0000716_abnormal_immune_system | 1.09516908 |
| 56 | MP0003724_increased_susceptibility_to | 1.08020137 |
| 57 | MP0001853_heart_inflammation | 1.07974116 |
| 58 | MP0000516_abnormal_urinary_system | 1.05322734 |
| 59 | MP0005367_renal/urinary_system_phenotyp | 1.05322734 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.05152315 |
| 61 | MP0005334_abnormal_fat_pad | 1.02997998 |
| 62 | MP0005410_abnormal_fertilization | 1.02562048 |
| 63 | MP0004510_myositis | 1.02493029 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.02244978 |
| 65 | MP0000249_abnormal_blood_vessel | 0.99601482 |
| 66 | MP0004858_abnormal_nervous_system | 0.97693534 |
| 67 | MP0002398_abnormal_bone_marrow | 0.97149771 |
| 68 | MP0003279_aneurysm | 0.96299203 |
| 69 | MP0002971_abnormal_brown_adipose | 0.95291457 |
| 70 | MP0008469_abnormal_protein_level | 0.93919014 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 0.93256095 |
| 72 | MP0002722_abnormal_immune_system | 0.92093228 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 0.91531671 |
| 74 | MP0002429_abnormal_blood_cell | 0.91379891 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.91097096 |
| 76 | MP0003123_paternal_imprinting | 0.86225560 |
| 77 | MP0001502_abnormal_circadian_rhythm | 0.84817328 |
| 78 | MP0002132_abnormal_respiratory_system | 0.84277037 |
| 79 | MP0003091_abnormal_cell_migration | 0.84120316 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.83273811 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.81062698 |
| 82 | MP0008260_abnormal_autophagy | 0.80526413 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.79995289 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.79995289 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.79866664 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.79418237 |
| 87 | MP0003878_abnormal_ear_physiology | 0.79418237 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.77892924 |
| 89 | MP0001958_emphysema | 0.77751799 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.77381757 |
| 91 | MP0000604_amyloidosis | 0.75705527 |
| 92 | MP0005164_abnormal_response_to | 0.75656524 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.74986924 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.74694624 |
| 95 | MP0001849_ear_inflammation | 0.73799707 |
| 96 | MP0008874_decreased_physiological_sensi | 0.72625474 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.71281453 |
| 98 | MP0003828_pulmonary_edema | 0.69147426 |
| 99 | MP0005390_skeleton_phenotype | 0.68752520 |
| 100 | MP0005448_abnormal_energy_balance | 0.68319342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic obstructive pulmonary disease (HP:0006510) | 3.77269266 |
| 2 | Obstructive lung disease (HP:0006536) | 3.77269266 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.56439463 |
| 4 | Abnormality of the prostate (HP:0008775) | 3.32892928 |
| 5 | Chest pain (HP:0100749) | 3.26836951 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.24790809 |
| 7 | Dysostosis multiplex (HP:0000943) | 3.22651190 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.06830037 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06343537 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06343537 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06343537 |
| 12 | Hepatosplenomegaly (HP:0001433) | 3.01357652 |
| 13 | Ureteral stenosis (HP:0000071) | 2.98673731 |
| 14 | Generalized hyperpigmentation (HP:0007440) | 2.94153972 |
| 15 | Asymmetric septal hypertrophy (HP:0001670) | 2.88201551 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 2.78127833 |
| 17 | Cellulitis (HP:0100658) | 2.68144409 |
| 18 | J-shaped sella turcica (HP:0002680) | 2.67574677 |
| 19 | Colitis (HP:0002583) | 2.65073162 |
| 20 | Porencephaly (HP:0002132) | 2.62464191 |
| 21 | Meningitis (HP:0001287) | 2.61133866 |
| 22 | Ureteral obstruction (HP:0006000) | 2.59334202 |
| 23 | Cutaneous photosensitivity (HP:0000992) | 2.57216831 |
| 24 | Loss of speech (HP:0002371) | 2.56053185 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.53743558 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.52789147 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52654332 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52654332 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52654332 |
| 30 | Polygenic inheritance (HP:0010982) | 2.49175845 |
| 31 | Thrombocytosis (HP:0001894) | 2.48609386 |
| 32 | Hypertriglyceridemia (HP:0002155) | 2.48278716 |
| 33 | Hemorrhage of the eye (HP:0011885) | 2.47604463 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.47148128 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46282089 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.46282089 |
| 37 | Prolonged neonatal jaundice (HP:0006579) | 2.39685883 |
| 38 | Nasal polyposis (HP:0100582) | 2.36591683 |
| 39 | Myositis (HP:0100614) | 2.35269680 |
| 40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34752015 |
| 41 | Cervical subluxation (HP:0003308) | 2.30089915 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.28974635 |
| 43 | Vertebral compression fractures (HP:0002953) | 2.28929005 |
| 44 | Pustule (HP:0200039) | 2.28104585 |
| 45 | Restrictive lung disease (HP:0002091) | 2.25642762 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.25406385 |
| 47 | Stridor (HP:0010307) | 2.25254149 |
| 48 | Flat occiput (HP:0005469) | 2.25072263 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.24363306 |
| 50 | Broad face (HP:0000283) | 2.24120356 |
| 51 | Increased muscle lipid content (HP:0009058) | 2.18887326 |
| 52 | Thin bony cortex (HP:0002753) | 2.18440937 |
| 53 | Joint stiffness (HP:0001387) | 2.17484386 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.17477176 |
| 55 | Mesangial abnormality (HP:0001966) | 2.15239267 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.14392276 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12681274 |
| 58 | Protrusio acetabuli (HP:0003179) | 2.12343837 |
| 59 | Epistaxis (HP:0000421) | 2.11300469 |
| 60 | Xanthomatosis (HP:0000991) | 2.10881007 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.09376432 |
| 62 | Hemoptysis (HP:0002105) | 2.07768309 |
| 63 | Increased IgE level (HP:0003212) | 2.04542345 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.03661708 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03478426 |
| 66 | Emphysema (HP:0002097) | 2.02275655 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.01075587 |
| 68 | Easy fatigability (HP:0003388) | 2.01049177 |
| 69 | Recurrent skin infections (HP:0001581) | 1.98183591 |
| 70 | Abnormality of complement system (HP:0005339) | 1.97200701 |
| 71 | Gingivitis (HP:0000230) | 1.96808434 |
| 72 | Hypertensive crisis (HP:0100735) | 1.94310370 |
| 73 | Abnormality of the pleura (HP:0002103) | 1.92844187 |
| 74 | Prostate neoplasm (HP:0100787) | 1.91249337 |
| 75 | Pulmonary fibrosis (HP:0002206) | 1.89320725 |
| 76 | Distal lower limb amyotrophy (HP:0008944) | 1.88951719 |
| 77 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88503845 |
| 78 | Increased connective tissue (HP:0009025) | 1.87984651 |
| 79 | Rhabdomyolysis (HP:0003201) | 1.87356366 |
| 80 | Abnormality of male internal genitalia (HP:0000022) | 1.86213765 |
| 81 | Abnormality of chloride homeostasis (HP:0011422) | 1.85329172 |
| 82 | Psychosis (HP:0000709) | 1.84594170 |
| 83 | Abnormal blistering of the skin (HP:0008066) | 1.84428445 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 1.84041681 |
| 85 | Vasculitis (HP:0002633) | 1.83142341 |
| 86 | Thin skin (HP:0000963) | 1.82402418 |
| 87 | Fragile skin (HP:0001030) | 1.80539404 |
| 88 | Nonimmune hydrops fetalis (HP:0001790) | 1.80422725 |
| 89 | Gastrointestinal stroma tumor (HP:0100723) | 1.80087966 |
| 90 | Plagiocephaly (HP:0001357) | 1.79571896 |
| 91 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79550335 |
| 92 | Bulbar palsy (HP:0001283) | 1.79111498 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 1.78845619 |
| 94 | Bell-shaped thorax (HP:0001591) | 1.78701436 |
| 95 | Abdominal distention (HP:0003270) | 1.78331672 |
| 96 | Premature rupture of membranes (HP:0001788) | 1.77252886 |
| 97 | Nuclear cataract (HP:0100018) | 1.76227985 |
| 98 | Acanthosis nigricans (HP:0000956) | 1.76132234 |
| 99 | Clumsiness (HP:0002312) | 1.74879511 |
| 100 | Amyloidosis (HP:0011034) | 1.74783270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CCNB1 | 5.27674816 |
| 2 | NEK2 | 4.87362557 |
| 3 | ERN1 | 4.61947918 |
| 4 | SMG1 | 3.85485937 |
| 5 | CAMKK2 | 3.07875170 |
| 6 | CAMK1D | 3.01196461 |
| 7 | TESK2 | 2.94028884 |
| 8 | TRIB3 | 2.86704151 |
| 9 | MAP4K1 | 2.74822545 |
| 10 | TESK1 | 2.64723793 |
| 11 | VRK2 | 2.16378495 |
| 12 | PRPF4B | 2.08147709 |
| 13 | IRAK3 | 1.93186240 |
| 14 | CAMK1G | 1.85996344 |
| 15 | LRRK2 | 1.74091076 |
| 16 | MAP3K11 | 1.65140095 |
| 17 | MAP3K7 | 1.58532521 |
| 18 | NME2 | 1.53999226 |
| 19 | TAF1 | 1.51441607 |
| 20 | CAMKK1 | 1.45654066 |
| 21 | SIK1 | 1.45423599 |
| 22 | CHUK | 1.32265048 |
| 23 | TBK1 | 1.30654413 |
| 24 | MARK2 | 1.28743357 |
| 25 | TNK2 | 1.14592281 |
| 26 | TYK2 | 1.12085569 |
| 27 | MAP2K3 | 1.09821139 |
| 28 | MST1R | 1.09273740 |
| 29 | KDR | 1.06320408 |
| 30 | HIPK2 | 1.04027306 |
| 31 | ICK | 1.03859301 |
| 32 | EPHA2 | 0.95655200 |
| 33 | IKBKE | 0.92838684 |
| 34 | CSK | 0.91724255 |
| 35 | ZAP70 | 0.91664996 |
| 36 | TXK | 0.89919509 |
| 37 | BLK | 0.86548268 |
| 38 | CDC42BPA | 0.84189234 |
| 39 | DDR2 | 0.83554134 |
| 40 | GRK6 | 0.82658293 |
| 41 | CAMK1 | 0.81454394 |
| 42 | PRKD2 | 0.78140772 |
| 43 | MAP3K13 | 0.77971816 |
| 44 | MAP3K1 | 0.76786428 |
| 45 | JAK3 | 0.75855568 |
| 46 | MAP3K3 | 0.75851771 |
| 47 | TTN | 0.75497444 |
| 48 | RIPK4 | 0.71043847 |
| 49 | PAK4 | 0.70527738 |
| 50 | ABL2 | 0.68801633 |
| 51 | SYK | 0.67751945 |
| 52 | IKBKB | 0.63781355 |
| 53 | PDPK1 | 0.63370284 |
| 54 | PIM2 | 0.63012268 |
| 55 | PKN2 | 0.62177760 |
| 56 | MAPK4 | 0.62003712 |
| 57 | DYRK1B | 0.59342317 |
| 58 | TAOK2 | 0.58003623 |
| 59 | BTK | 0.56506290 |
| 60 | MAPK15 | 0.56055605 |
| 61 | MAP2K2 | 0.54286067 |
| 62 | KIT | 0.53885237 |
| 63 | MAP3K14 | 0.53032319 |
| 64 | RIPK1 | 0.52288082 |
| 65 | FES | 0.50764172 |
| 66 | PRKAA2 | 0.50598951 |
| 67 | CSF1R | 0.49262249 |
| 68 | RPS6KL1 | 0.47826190 |
| 69 | RPS6KC1 | 0.47826190 |
| 70 | EPHB1 | 0.47364706 |
| 71 | MAPK11 | 0.45000851 |
| 72 | BMX | 0.44345013 |
| 73 | ARAF | 0.43343051 |
| 74 | PRKD3 | 0.43170876 |
| 75 | IRAK4 | 0.42379550 |
| 76 | LIMK1 | 0.41340215 |
| 77 | HCK | 0.41192056 |
| 78 | MTOR | 0.39605887 |
| 79 | GRK5 | 0.39528939 |
| 80 | CDK9 | 0.39464452 |
| 81 | RPS6KA6 | 0.36702954 |
| 82 | PDK1 | 0.36115332 |
| 83 | BCKDK | 0.36066102 |
| 84 | FGFR4 | 0.34861620 |
| 85 | PRKD1 | 0.33397839 |
| 86 | CAMK4 | 0.33255311 |
| 87 | RPS6KA2 | 0.32162326 |
| 88 | MAPKAPK5 | 0.31670676 |
| 89 | RPS6KB2 | 0.31466202 |
| 90 | DAPK3 | 0.30926849 |
| 91 | TAOK1 | 0.30589478 |
| 92 | EEF2K | 0.30489096 |
| 93 | STK38 | 0.29712571 |
| 94 | SCYL2 | 0.29498438 |
| 95 | MAP3K8 | 0.29047532 |
| 96 | LMTK2 | 0.28775568 |
| 97 | PTK6 | 0.28605997 |
| 98 | JAK1 | 0.28201353 |
| 99 | CDK7 | 0.27963797 |
| 100 | LCK | 0.27285801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.81375410 |
| 2 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 3.05098335 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.03790324 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.54762265 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.52517668 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.34420446 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.31385750 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29250098 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.87924623 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79097792 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78210774 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76265042 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76200602 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72975377 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.69450014 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64630231 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.58003290 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.49385197 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46091804 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43683030 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41207523 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38537370 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.33475468 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27916179 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.26799538 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.24424562 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22193609 |
| 28 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.17030230 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14582232 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.14501637 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.12361266 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09492998 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.09207551 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07538593 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.06460572 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05664425 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04070998 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03710410 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02623265 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02539861 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00238158 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99620680 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98006711 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97818664 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.95877031 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93494194 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92436813 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.90696976 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89598966 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87007277 |
| 51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86650331 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85791172 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84717414 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.84243269 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83875705 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.82016085 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81333246 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79103647 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78905960 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77937009 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77108412 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71069251 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70595164 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.70428048 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64533437 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64231634 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.62376766 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62117666 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61724937 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61025984 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60317110 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59388080 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59244512 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.58317455 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55443059 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.55373537 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55318303 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55310903 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53840972 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53275666 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52074883 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51193297 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50744235 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49028038 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47640610 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46173971 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46159092 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.45193330 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.43756084 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.42979298 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42150785 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.41591606 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40423505 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.40226079 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39829455 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39220662 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38906164 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36500831 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35844257 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35362131 |

